Michelle T. Long

Building frameworks for better understanding of liver diseases and their systemic impacts, Dr. Michelle T. Long serves as an Associate Professor of Medicine at Boston University. With a profound dedication to advancing the field of hepatology, she leads as the Director of the NAFLD Research Center and Clinical Research for Gastroenterology and Hepatology at Boston Medical Center. Her work is pivotal in exploring the intricate relationships between nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease, fibrosis, and inflammation, aiming to unravel the complexities of these interconnected conditions. Dr. Long's research is at the forefront of developing innovative treatments for NAFLD and nonalcoholic steatohepatitis (NASH), striving to improve patient outcomes through cutting-edge therapeutic strategies. Her expertise extends to the realms of epidemiology and visceral fat, where she investigates the broader implications of liver health on overall well-being. Her work in liver imaging has been instrumental in enhancing diagnostic accuracy and monitoring disease progression, providing valuable insights into the management of liver conditions. In addition to her focus on NAFLD, Dr. Long is deeply engaged in studying alcohol-related liver disease, contributing to a comprehensive understanding of liver health across different etiologies. Her research endeavors are complemented by her commitment to education, where she mentors the next generation of medical professionals and researchers, fostering a culture of inquiry and innovation. Dr. Long's contributions to the field are recognized through numerous publications and presentations at national and international conferences. Her collaborative approach and dedication to translational research ensure that her work not only advances scientific knowledge but also translates into tangible benefits for patients, making significant strides in the fight against liver disease.